Q4 & FY22 Highlights
Dr. Lal PathLabs - At a Glance
India's Leading & Trusted
Diagnostics Company
70+ years of experience
in the field of diagnostics
100 Mn patients serviced
in last 5 years
31 NABL accredited Labs;
National Reference Lab
accredited by CAP
Largest*
diagnostics
chain in the
country with
PAN India
presence and
consistent track
record of
quality and
growth
20%
3 Year Revenue
CAGR
20%
3-Year PAT
CAGR
120%
Equity Dividend
for FY 21-22
~44%
ROCE
Excl. Cash &
Investments
277
Labs;
Geographically
spread out
network
Rs. 344 crore (Net)
Cash & Investments as on
4,731
Patient Service
Centres (PSC's)
31st Mar, 22
5,113
Pathology &
Radiology tests;
Comprehensive
Test menu
As on March 31, 2022
*Largest on the basis of revenue and presence
Note: Figures includes Suburban Diagnostics w.e.f. 12th November 2021
5
Dr Lal PathLabsView entire presentation